SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

DASH is trending as discussions around privacy coins and comparisons to ZEC intensify, with traders speculating on potential gains. Community members are actively debating its future performance and whether it will follow a similar trajectory to other cryptocurrencies. Conversations also highlight DASH's limited supply and potential for significant price appreciation during the next bull run.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

KPTI is trending due to concerns around the company's leadership and financial management. Community discussions focus on the performance of the CEO, potential mismanagement, and the need for strategic changes. Upcoming phase 3 results are a key factor for the company's future, amid discussions about its cash runway and potential need for further financing.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

Internet Computer (ICP) is trending amidst discussions about its underlying technology and potential for growth, with some community members highlighting its long-term vision to decentralize the internet and challenge established cloud providers. Bullish sentiment centers on its strong technology, recent launch of Caffeine AI, and staking rewards, while bears cite concerns about its historical performance, tokenomics, and adoption rates. Speculation about increased volume, potential partnerships, and integration of Bitcoin DeFi are also circulating within the community.

Caesars Entertainment, Inc. engages in the management of casinos and resorts under the Caesars, Harrah's, Horseshoe, and Eldorado brands. It operates through the following segments: Las Vegas, Regional, Caesars Digital, Managed and Branded, and Corporate and Other. The company was founded in 1937 and is headquartered in Reno, NV.

Caesars Entertainment Inc

CZR is trending as investors digest recent earnings results and debate the company's future prospects, particularly its debt load and growth strategy in a competitive market. Community discussions revolve around the impact of tariffs, potential for a recession, and the attractiveness of the stock's valuation relative to its digital assets and real estate. Some traders are closely watching for a potential bottom and possible actions from activist investors like Carl Icahn.

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Dexcom Inc

DXCM is trending downwards amidst concerns regarding the accuracy and reliability of its G7 continuous glucose monitor, highlighted in a recent short report. The community is discussing the potential impact of these issues on Dexcom's market share and the possibility of a class action lawsuit. Some traders believe the stock is oversold and presents a buying opportunity, while others are wary of negative sentiment and potential for further decline.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot (DOT) is trending amid mixed sentiments, with some traders eyeing potential gains from staking and anticipating a broader altcoin rally, while others express frustration with the project's performance and leadership. Discussions include potential catalysts such as ETF approvals and interoperability solutions, alongside debates about its long-term viability and tokenomics. Community members are actively weighing the risks and opportunities surrounding DOT within the current market cycle.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

ZVRA is trending as rumors of potential acquisition swirl, with the community buzzing about a potential buyout after reports of a failed financing attempt from a smaller company.  Enthusiasm is building for the upcoming earnings report and the potential for a positive outcome, while some investors express skepticism toward management. Bullish sentiment is further fueled by high short interest, leading to speculation about a possible short squeeze.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

HTZ is trending due to a partnership with Amazon to sell used cars online, sparking discussions about its potential to challenge competitors like Carvana and boost retail visibility. The community is analyzing the potential for a short squeeze, fueled by high short interest and Ackman's involvement, while also considering the company's debt and upcoming earnings.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23

Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that CEO, Jennifer Ernst, will participate in the eighth annual Constellation Forum, a global...

Tivic Receives Two Investigational New Drug Applications for Entolimod for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers

Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced it has received, from Statera Biopharma, two investigational new drug applications (INDs) for its...

Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025

Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, is proud to announce it advanced discussions with key US Government agencies through its participation in the 2025...

Shares of Tivic Health Systems, Inc. (TIVC) doubled on Tuesday after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.tivichealth.com/tivic-health-reports-white-house-briefing-and-fda-meetings-secured-positive-interest-in-potential-military-and-defense-applications-of-its-product-candidates/">said</a> it has garnered “significant positive interest” in potential military and defense applications for its biologic and bioelectronic product candidates following two meetings held in Washington, D.C.Tivic Health provided briefings to senior leadership at the White House and the Food and Drug Administration (FDA) in Washington, D.C. on April 17th.During the meeting with the White House, the company highlighted the need for advanced treatments for acute radiation syndrome in the United States and its allied countries.Tivic Health’s biopharma program’s lead product candidate, Entolimod, is in late-stage studies for the treatment of acute radiation syndrome.Tivic is also preparing to initiate a phase 2 clinical study for Entolimod for the treatment of Neutropenia, a condition characterized by lower-than-normal levels of neutrophils, a type of white blood cell essential for combating infections.The company also discussed the potential for expedited pathways and support for export opportunities for Entolimod and Tivic’s non-invasive cervical vagus nerve stimulation (ncVNS) technology in a separate meeting with senior leaders of the FDA. &nbsp;Tivic Health’s ncVNS program is advancing medical devices to provide treatments for inflammatory, cardiac, and neurologic disorders.The company said that vagus nerve stimulation has shown “strong potential” in the treatment of post-traumatic stress disorder (PTSD), a neurologic disorder of interest to the military.Tivic CEO Jennifer Ernst said that the meetings were informal in nature and more discussions are expected as the company’s Entolimod and ncVNS medical programs progress toward potential FDA approval.On Stocktwits, retail sentiment around Tivic Health remained bearish over the past 24 hours while message volume remained at ‘extremely low’ levels.<figure class="image"><img style="aspect-ratio:647/145;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_22_at_12_05_02_PM_png_89e18ee138.webp" alt="TIVC's Sentiment Meter and Message Volume as of 12:05 p.m. ET on April 22, 2025 | Source: Stocktwits" width="647" height="145"><figcaption>TIVC's Sentiment Meter and Message Volume as of 12:05 p.m. ET on April 22, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/TIVC">TIVC stock</a> is up by over 19% so far this year but down by over 65% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/rivian-expands-board-adds-aidan-gomez-as-director/chQSuj1RbXk">Rivian Expands Board, Adds Cohere CEO Aidan Gomez As Director: But Retail Stays Bearish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

Tivic Health Stock Doubles After Briefings To Senior Leadership At White House, FDA: But Retail Stays Bearish

During the meeting with the White House, the company highlighted the need for advanced treatments for acute radiation syndrome in the United States and its allied countries.

Equity

Tivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership Team

Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, announced today that Michael K. Handley, formerly Chief Executive Officer, President and Chairman of Statera Biopharma...

Shares of The Real Good Food Company ($RGF) dived nearly 65% on Monday as the company announced it received a delisting notice from The Nasdaq, dampening retail sentiment.Real Good Food, a maker of refrigerated foods, said it was no longer in compliance with Nasdaq Listing 5250(c)(1) for failure to file periodic financial reports.Trading in its common stock on Nasdaq will be suspended on January 7.Its common stock is expected to commence trading on the Pink Open Market operated by the OTC Markets Group Inc. (“OTC”), referred to as the “pink sheets,” commencing on January 7.The company warned that trading may ultimately move to OTC’s “Expert Market,” where quotes for the company’s common stock will no longer be available for public viewing.Retail sentiment on Stocktwits seemed bearish with commenters expressing surprise given its recent reverse stock split.<stembedurl>https://stocktwits.com/DisgruntledbutzenDavid/message/599043071</stembedurl>Last month, Real Good Food announced a 12-to-reverse stock split, sparking retail chatter on Stocktwits. According to a company statement, the stock split consisted of its Class A common stock, par value $0.0001, and Class B common stock, par value $0.0001, set to become effective at 5:00 pm ET on January 3. The stock split was to affect all holders of its common stock uniformly, the company said.Real Good Food posted a loss per share of $0.50 for its third quarter, compared to the $0.20 that analysts expected.Real Good Food stock is down nearly 70% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Real Good Food Stock Dives On Nasdaq Delisting: Retail Mood Sours 

The company warned that trading may ultimately move to OTC’s “Expert Market,” where quotes for the company’s common stock will no longer be available for public viewing.

CEO Letter to Shareholders Issued by Tivic Health

Tivic Health Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, today released its annual CEO letter to shareholders. Dear Fellow Shareholders...

Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update

Tivic Health Systems, Inc. (Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced third quarter and nine-months ended September, 30, 2024...

Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device

Tivic Health Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that full enrollment has been completed in the optimization...

Tivic Health Validates European Patents in Great Britain, Germany, and France

Tivic Health Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicinal devices, announced today that it has validated two granted European Patent...

Tivic Health Systems, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company was founded by Jennifer Ernst and John Claude on September 22, 2016 and is headquartered in Fremont, CA.

Tivic Health Systems Inc

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Palantir Technologies Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$2.51
Prev Close	$2.50
Open	$2.41
Dividend Yield	0.00%
50-Day Moving Average	$2.96
Beta	0.94
Avg. Volume	105,032.38
PE Ratio	-0.22

52-Week High	$15.64
52-Week Low	$2.40
Market Capitalization	$4.26M
EPS (Annual)	-$19.68
Price to Book	0.66
Revenue Per Employee	$86,666.67
Enterprise Value/EBITDA	N/A

TIVC
Tivic Health Systems Inc

Feed

News

Sentiment

Fundamentals

Info

Latest TIVC News

TIVCTivic Health Systems Inc